Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,201 to 1,220 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. | Front Immunol | 2021 | 34054873 | PubTator, text mining | PubMed |
| The Chlamydia trachomatis Tarp effector targets the Hippo pathway. | Biochem Biophys Res Commun | 2021 | 34052658 | PubTator, text mining | PubMed |
| GPCR-mediated YAP/TAZ inactivation in fibroblasts via EPAC1/2, RAP2C, and MAP4K7. | J Cell Physiol | 2021 | 34046891 | PubTator, text mining | PubMed |
| Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues. | Nat Commun | 2021 | 34035288 | PubTator, text mining | PubMed |
| SARS-CoV-2 variants of concern partially escape humoral but not T-cell responses in COVID-19 convalescent donors and vaccinees. | Sci Immunol | 2021 | 34035118 | PubTator, text mining | PubMed |
| In vivo genome-wide CRISPR screen reveals breast cancer vulnerabilities and synergistic mTOR/Hippo targeted combination therapy. | Nat Commun | 2021 | 34031411 | PubTator, text mining | PubMed |
| The Role of Neurodevelopmental Pathways in Brain Tumors. | Front Cell Dev Biol | 2021 | 34012965 | PubTator, text mining | PubMed |
| Mst1/2 Kinases Inhibitor, XMU-MP-1, Attenuates Angiotensin II-Induced Ascending Aortic Expansion in Hypercholesterolemic Mice. | Circ Rep | 2021 | 34007939 | PubTator, text mining | PubMed |
| Regulation of ferroptosis in cancer cells by YAP/TAZ and Hippo pathways: The therapeutic implications. | Genes Dis | 2021 | 33997171 | PubTator, text mining | PubMed |
| Comprehensive biological function analysis of lncRNAs in hepatocellular carcinoma. | Genes Dis | 2021 | 33997162 | PubTator, text mining | PubMed |
| Hippo Pathway Core Genes Based Prognostic Signature and Immune Infiltration Patterns in Lung Squamous Cell Carcinoma. | Front Oncol | 2021 | 33996611 | PubTator, text mining | PubMed |
| Regulatory effect of microRNA-223-3p on breast cancer cell processes via the Hippo/Yap signaling pathway. | Oncol Lett | 2021 | 33986876 | PubTator, text mining | PubMed |
| Role of ARK5 in cancer and other diseases (Review). | Exp Ther Med | 2021 | 33986861 | PubTator, text mining | PubMed |
| Regulation and mechanism of YAP/TAZ in the mechanical microenvironment of stem cells (Review). | Mol Med Rep | 2021 | 33982785 | PubTator, text mining | PubMed |
| The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients. | PLoS One | 2021 | 33970925 | PubTator, text mining | PubMed |
| The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. | Front Oncol | 2021 | 33968749 | PubTator, text mining | PubMed |
| Characterization of Frequently Mutated Cancer Genes and Tumor Mutation Burden in Chinese Breast Cancer. | Front Oncol | 2021 | 33968723 | PubTator, text mining | PubMed |
| Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver disease. | J Hepatol | 2021 | 33964370 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Pharmaceuticals targeting signaling pathways of endometriosis as potential new medical treatment: A review. | Med Res Rev | 2021 | 33948974 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=61